教育经历 2005.9~2010.9 华中科技大学 研究生(博士)毕业 2001.9~2005.6 华中师范大学 本科(学士) 工作经历 2023.3~至今 华中科技大学 生命科学与技术学院 教授 2015.7~2023.3 华中科技大学 生命科学与技术学院 副教授 2010.10~2015.6 华中科技大学 生命科学与技术学院 博士后

心脑血管疾病数字化生物标志物 代谢系统疾病遗传与分子机制 心脑血管疾病遗传机制与转化医学研究

徐承启.AGGF1 therapy inhibits thoracic aortic aneurysms by enhancing integrin α7-mediated inhibition of TGF-β1 maturation and ERK1/2 signaling.NATURE COMMUNICATIONS,2023,(1):2265 徐承启.Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1.JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE,2023,(2):978-991 徐承启.Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R/EGR1/PDGF-BB signaling pathway.METABOLISM-CLINICAL AND EXPERIMENTAL,2023,(140):155380 徐承启.NINJ2 deficiency inhibits preadipocyte differentiation and promotes insulin resistance through regulating insulin signaling.Obesity,2023,(1):123-138 徐承启.Role of epigenetic m6A RNA methylation in vascular development: mettl3 regulates vascular development through PHLPP2/mTOR-AKT signaling.FASEB JOURNAL,2021,(5):e21465 徐承启.A genome-wide association study identifies novel association between genetic variants in GGT7 and LINC00944 and hypertension.CLINICAL AND TRANSLATIONAL MEDICINE,2021,(5):e388